文献

J-GLOBAL ID：202002269457620646   整理番号：20A0576153

低悪性度漿液性卵巣癌:科学の状態【JST・京大機械翻訳】

Low-grade serous ovarian cancer: State of the science

著者 (30件)： Slomovitz Brian (Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States) ,  Gourley Charlie (Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK) ,  Carey Mark S. (Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada) ,  Malpica Anais (Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States) ,  Shih Ie-Ming (Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States) ,  Huntsman David (Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada) ,  Fader Amanda N. (Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States) ,  Grisham Rachel N. (Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States) ,  Grisham Rachel N. (Weil Cornell Medical College, New York, NY, United States) ,  Schlumbrecht Matthew (Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States) ,  Sun Charlotte C. (Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States) ,  Ludemann Jane (Cure Our Ovarian Cancer, cureourovariancancer.org, New Zealand) ,  Cooney Gail Austin (University of Miami/JFK Medical Center Palm Beach Regional Graduate Medical Education Consortium, Hospice and Palliative Medicine Program, West Palm Beach, FL, United States) ,  Coleman Robert (Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States) ,  Sood Anil K. (Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States) ,  Mahdi Haider (Department of Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic, Cleveland, OH, United States) ,  Mahdi Haider (Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States) ,  Wong Kwong K. (Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States) ,  Covens Allan (University of Toronto, Division of Gynecologic Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada) ,  O’Malley David M. (Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, The James CCC at the Wexner Medical Center-The Ohio State University College of Medicine, Columbus, OH, United States) ,  Lecuru Fabrice (Service de Chirurgie Cancerologique Gynecologique et du Sein, Hopital Europeen George Pompidou, APHP, Paris, France) ,  Lecuru Fabrice (Faculte de Medecine, Universite Paris Descartes, Paris, France) ,  Cobb Lauren P. (Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States) ,  Caputo Thomas A. (Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, United States) ,  May Taymaa (Division of Gynecologic Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada) ,  Huang Marilyn (Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States) ,  Siemon John (Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States) ,  Fernandez Marta Llaurado (Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada) ,  Ray-Coquard Isabelle (Centre Leon Berard, Universite Claude Bernard Lyon, Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire (GINECO), Lyon, France) ,  Gershenson David M. (Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States)
資料名： Gynecologic Oncology  (Gynecologic Oncology)
巻： 156  号： 3  ページ： 715-725  発行年： 2020年 
JST資料番号： E0561C  ISSN： 0090-8258  資料種別： 逐次刊行物 (A)
記事区分： 文献レビュー  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： 2019年1月に,Flor田における基礎的,翻訳的,臨床的研究者と患者の集団が,卵巣の低悪性しょう液癌の科学の現状を議論するか,または,漿液性境界腫瘍の診断に従って起こる可能性のある稀な卵巣癌サブタイプを検討した。会議の目的は,現在の知識をレビューし,確立された研究者による進行中の研究,および将来の方向に対する枠組みの重要な疑問または課題を議論することであった。提示と議論の後,主要な目的は,この疾患をより良く理解し,単一学術機関の境界外で臨床ケアを進めるために,将来の協力,均一なデータベースプラットフォーム,実験室研究,および臨床試験を開始することであった。本レビューは,5つの主要なカテゴリーにおける科学の状態をまとめる:疫学と患者の結果,病理学,トランスレーショナル研究,患者ケアと臨床試験,および患者の展望。Copyright 2020 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： データベース ,  腫瘍 ,  *卵巣 ,  疫学 ,  *卵巣腫瘍 ,  臨床試験 ,  腹膜
準シソーラス用語： 患者介護 ,  臨床ケア ,  *悪性度 , 【Automatic Indexing@JST】

著者キーワード (3件)： 卵巣の低悪性度漿液性癌 ,  腹膜の低悪性度漿液性癌 ,  上皮性卵巣癌

分類 (1件)： 女性生殖器と胎児の腫よう  (GS04000K)

タイトルに関連する用語 (3件)： 悪性度 ,  漿液性卵巣癌 ,  科学